These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33407602)

  • 1. Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
    Xu Y; Ma X; Zhou Z; Li J; Hou J; Zhu J; Kang M; Lai J; Li X
    Pediatr Rheumatol Online J; 2021 Jan; 19(1):2. PubMed ID: 33407602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
    Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
    Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody.
    Fu Y; Gu L; Chen J; Dai Y; Feng Q; Chen Z; Fan J; Gao M; Wang X; Fu Q; Ye S
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38199847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature.
    Chang Y; Shan X; Ge Y
    Pediatr Rheumatol Online J; 2023 Sep; 21(1):106. PubMed ID: 37735702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medications received by patients with juvenile dermatomyositis.
    Kishi T; Bayat N; Ward MM; Huber AM; Wu L; Mamyrova G; Targoff IN; Warren-Hicks WJ; Miller FW; Rider LG;
    Semin Arthritis Rheum; 2018 Dec; 48(3):513-522. PubMed ID: 29773230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile dermatomyositis with central nervous system involvement: two case reports from a retrospective single-center cohort, with literature review.
    Yang L; Guan W; Liu H; Li Y; Gong Y; Lv Q; Zeng Q; Wei Q; Zhang X; Chen W; Chen C; Sun L
    Front Pediatr; 2024; 12():1409950. PubMed ID: 38873583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible correlation between serum interleukin-8 levels and the activity of myositis in anti-NXP2 antibody-positive dermatomyositis.
    Konishi R; Ichimura Y; Tanaka R; Miyahara H; Okune M; Miyamoto M; Hara M; Iwabuchi A; Takada H; Nakagishi Y; Mizuta M; Kaneko S; Shimizu M; Morio T; Nishino I; Nomura T; Okiyama N
    Immunol Med; 2024 Jun; 47(2):100-105. PubMed ID: 38174692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report.
    Nainia K; Aouzal MA; Ouafik I; Charhbili M; Bouchhab A; Daoudi A; Tizki S; Chakiri R
    Pediatr Rheumatol Online J; 2024 May; 22(1):57. PubMed ID: 38773611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile dermatomyositis complications: navigating gastrointestinal perforations and treatment challenges, a case report.
    Xiangyuan C; Xiaoling Z; Guangchao S; Huasong Z; Dexin L
    Front Pediatr; 2024; 12():1419355. PubMed ID: 39070551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.
    Deakin CT; Yasin SA; Simou S; Arnold KA; Tansley SL; Betteridge ZE; McHugh NJ; Varsani H; Holton JL; Jacques TS; Pilkington CA; Nistala K; Wedderburn LR;
    Arthritis Rheumatol; 2016 Nov; 68(11):2806-2816. PubMed ID: 27214289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-NXP2 Antibody-positive Juvenile Dermatomyositis with Characteristic Fascial Thickening on Muscle Ultrasound and Improvement with Immunotherapy.
    Fukushima K; Yoshida T; Yamazaki H; Takamatsu N; Nagai T; Osaki Y; Harada M; Nishino I; Okiyama N; Sugie K; Izumi Y
    Intern Med; 2024 Jun; 63(12):1813-1817. PubMed ID: 37926535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
    Mamyrova G; Kishi T; Targoff IN; Ehrlich A; Curiel RV; Rider LG;
    Rheumatology (Oxford); 2018 Nov; 57(11):1956-1963. PubMed ID: 30016492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-depth proteomic analysis of juvenile dermatomyositis serum reveals protein expression associated with muscle-specific autoantibodies.
    Sato H; Inoue Y; Kawashima Y; Konno R; Ohara O; Kuwana M; Kobayashi N; Takezaki S; Akioka S
    Rheumatology (Oxford); 2023 Oct; 62(10):3501-3506. PubMed ID: 37052527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-nuclear matrix protein 2 antibody-positive dermatomyositis with gastrointestinal ulcers: A case report.
    Uchio N; Komaki S; Sudo T; Matsumoto Y; Hao A; Kojima K; Toda N; Kitamura A; Maeda MH; Kubota A; Matsumoto H
    Int J Rheum Dis; 2023 Dec; 26(12):2572-2575. PubMed ID: 37287416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over Activation of IL-6/STAT3 Signaling Pathway in Juvenile Dermatomyositis.
    Zheng Q; Wang Z; Tan Y; Zhu K; Lu M
    Rheumatol Ther; 2024 Oct; 11(5):1255-1269. PubMed ID: 39073510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcinosis in Juvenile Dermatomyositis-Epidemiology, Pathogenesis, Clinical Features, and Treatment: A Systematic Review.
    Gonçalves Júnior J; Shinjo SK
    Curr Rheumatol Rep; 2024 Feb; 26(2):53-68. PubMed ID: 38060107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis.
    Karasawa R; Yudoh K; Sato T; Tanaka M; Sabbagh SE; Flegel WA; Mammen AL; Jarvis JN; Rider LG;
    Rheumatology (Oxford); 2023 Nov; 62(11):3757-3762. PubMed ID: 37144941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis.
    Karasawa R; Yudoh K; Sato T; Tanaka M; Tamaki M; Sabbagh SE; O'Hanlon TP; Noroozi-Farhadi P; Targoff IN; Flegel WA; Mammen AL; Miller FW; Hicar MD; Rider LG; Jarvis JN
    Rheumatology (Oxford); 2022 Jul; 61(7):2969-2977. PubMed ID: 34791087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity.
    Pachman LM; Morgan G; Klein-Gitelman MS; Ahsan N; Khojah A
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):118. PubMed ID: 37828536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile Dermatomyositis in Afro-Caribbean children: a cohort study in the French West Indies.
    Felix A; Delion F; Louis-Sidney F; Osei L; Armougon A; Bellance R; Dramé M; Deligny C; Suzon B; Hatchuel Y
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):113. PubMed ID: 37805487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.